These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Prostacyclin--its function and indications for therapeutic use]. Ram R; Levy Y; Shoenfeld Y Harefuah; 2000 Jan; 138(1):54-8. PubMed ID: 10868182 [No Abstract] [Full Text] [Related]
23. Antiplatelet agents: current drugs and future trends. Messmore HL; Jeske WP; Wehrmacher W; Coyne E; Mobarhan S; Cho L; Leya FS; Moran JF Hematol Oncol Clin North Am; 2005 Feb; 19(1):87-117, vi. PubMed ID: 15639110 [TBL] [Abstract][Full Text] [Related]
24. [Preventive treatment of cerebrovascular accidents of arterial origin]. Castillo V; Bogousslavsky J; Vuadens P Praxis (Bern 1994); 1996 Feb; 85(6):159-63. PubMed ID: 8701178 [TBL] [Abstract][Full Text] [Related]
25. Clopidogrel's role in the management of atherosclerotic disease: a focus on acute coronary syndromes. Rodgers JE; Steinhubl SR Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):507-21. PubMed ID: 15030250 [TBL] [Abstract][Full Text] [Related]
26. [Mechanisms of platelet activation and development of antiplatelet agents]. Cazenave JP; Gachet C; Lanza F Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1501-6. PubMed ID: 9092410 [TBL] [Abstract][Full Text] [Related]
27. Antithrombotic drugs in vascular medicine: a historical perspective. Schrör K Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472 [TBL] [Abstract][Full Text] [Related]
28. [Peripheral arterial revascularization: which antithrombotic agents?]. Haulon S; Susen S; Koussa M; Jude B Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970 [TBL] [Abstract][Full Text] [Related]
29. [The future prospects of antithrombotic therapy in peripheral vasculopathy]. Violi F; Loffredo L; Annessi M Ann Ital Med Int; 1999; 14(3):185-91. PubMed ID: 10566184 [TBL] [Abstract][Full Text] [Related]
30. Platelets and vascular disease. Moser M; Bode C Hamostaseologie; 2009 Nov; 29(4):319. PubMed ID: 19998750 [No Abstract] [Full Text] [Related]
31. [Drug therapy of diabetic retinopathy. The beginning of hope?]. Guillausseau PJ Rev Prat; 1992 Apr; 42(7):864-6. PubMed ID: 1604207 [No Abstract] [Full Text] [Related]
34. [Prevention and early treatment of diabetic retinopathy]. Matsuyama S Nippon Ganka Gakkai Zasshi; 1990 Jan; 94(1):89-90. PubMed ID: 2360492 [No Abstract] [Full Text] [Related]
35. [Platelet antiaggregants: a review of their indications in primary care]. Blasco Valle M; Vitoria Lapeña A; Robledo E Aten Primaria; 1993 Feb; 11(3):142-6, 148-50. PubMed ID: 8453007 [No Abstract] [Full Text] [Related]
36. Prevalence and characteristics of antiplatelet therapy without overt occlusive vascular disease among hospitalized older patients. Komagamine J Geriatr Gerontol Int; 2017 Sep; 17(9):1335-1337. PubMed ID: 28960705 [No Abstract] [Full Text] [Related]